Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um, A Bershteyn… - Nature medicine, 2010 - nature.com
A major limitation of cell therapies is the rapid decline in viability and function of the
transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation …

[PDF][PDF] Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um… - NATURE …, 2010 - faculty.washington.edu
RESULTS Stable nanoparticle attachment to cell surfaces To stably couple synthetic drug-
carrier nanoparticles to the surface of therapeutic cells, we exploited the fact that many cells …

[PDF][PDF] Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um… - NATURE …, 2010 - s3.us-east-1.amazonaws.com
RESULTS Stable nanoparticle attachment to cell surfaces To stably couple synthetic drug-
carrier nanoparticles to the surface of therapeutic cells, we exploited the fact that many cells …

[引用][C] Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um, A Bershteyn, DJ Irvine - Nature Medicine, 2010 - cir.nii.ac.jp
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索フォ恁啶匾動 論文·デ恁郡 …

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um… - Nature …, 2010 - pubmed.ncbi.nlm.nih.gov
A major limitation of cell therapies is the rapid decline in viability and function of the
transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation …

[PDF][PDF] Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um, A Bershteyn… - NATURE …, 2010 - researchgate.net
RESULTS Stable nanoparticle attachment to cell surfaces To stably couple synthetic drug-
carrier nanoparticles to the surface of therapeutic cells, we exploited the fact that many cells …

[PDF][PDF] Therapeutic cell engineering using surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um, A Bershteyn, DJ Irvine - Nat Med, 2010 - immocell.com
A major limitation of cell therapies is the rapid decline in viability and function of transplanted
cells. Here we describe a strategy to enhance cell therapy via the conjugation of adjuvant …

[PDF][PDF] Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um… - NATURE …, 2010 - moonlab.engin.umich.edu
RESULTS Stable nanoparticle attachment to cell surfaces To stably couple synthetic drug-
carrier nanoparticles to the surface of therapeutic cells, we exploited the fact that many cells …

[PDF][PDF] Therapeutic cell engineering using surface-conjugated synthetic nanoparticles

MT Stephan, JJ Moon, SH Um, A Bershteyn, DJ Irvine - Nat Med, 2010 - Citeseer
A major limitation of cell therapies is the rapid decline in viability and function of transplanted
cells. Here we describe a strategy to enhance cell therapy via the conjugation of adjuvant …

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

MT Stephan, JJ Moon, SH Um, A Bershteyn… - Nature …, 2010 - search.ebscohost.com
A major limitation of cell therapies is the rapid decline in viability and function of the
transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation …